Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 10.8M | 11.46% | $ 94.24M |
3/31/2025 | $ 9.48M | 10.32% | $ 91.87M |
12/31/2024 | $ 8.88M | 9.82% | $ 90.4M |
9/30/2024 | $ 8.7M | 9.73% | $ 89.36M |
6/30/2024 | $ 8.61M | 10.13% | $ 85.01M |
3/31/2024 | $ 8.82M | 10.47% | $ 84.3M |
12/31/2023 | $ 9.36M | 11.32% | $ 82.71M |
9/30/2023 | $ 9.34M | 12.08% | $ 77.28M |
6/30/2023 | $ 8.99M | 12.4% | $ 72.52M |
3/31/2023 | $ 8.39M | 12.35% | $ 67.98M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for UROGEN PHARMA LTD is calculated as follows: COGS [ $ 357K ] / Revenues [ $ 3.83M ]
(=) COGS % [ 9.31% ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.81K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.91% |
median | 50.54% |
std | 31.59% |